SCHEMBL8282931

SCHEMBL8282931

N#CCC(=O)Nc1nc(CC(=O)O)cs1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.51
ABL1 P00519 1/20 0.51
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
POLB P06746 1/20 0.48
MAPT P10636 4/20 0.47
KDM4E B2RXH2 2/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
PDE5A O76074 5/20 0.47
ITGB1 P05556 1/20 0.47
ITGA4 P13612 1/20 0.47
GABRA5 P31644 1/20 0.46
GABRB2 P47870 1/20 0.46
HSD17B10 Q99714 1/20 0.46
GAA P10253 4/20 0.46
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21495034 0.81 PDE5A (0.51) ALDH1A1ABL1MEN1KMT2AMAPT
SCHEMBL8350301 0.81 ALDH1A1 (0.54) ALDH1A1MEN1KMT2APOLBMAPT
SCHEMBL6036808 0.81 ALDH1A1 (0.54) ALDH1A1MEN1KMT2APOLBMAPT
SCHEMBL7493963 0.81 ALDH1A1 (0.54) ALDH1A1MEN1KMT2APOLBMAPT
SCHEMBL7488591 0.78 KMT2A (0.53) ALDH1A1MEN1KMT2APOLBMAPT
SCHEMBL8283113 0.78 SMN1; SMN2 (0.57) ALDH1A1ABL1MEN1KMT2APOLB
SCHEMBL11359245 0.77 GABRA5 (0.57) ALDH1A1MEN1KMT2APOLBMAPT
SCHEMBL2788439 0.77 SMN1; SMN2 (0.69) ALDH1A1MEN1KMT2APOLBMAPT
SCHEMBL28100058 0.77 GABRA5 (0.71) ALDH1A1MEN1KMT2APOLBMAPT
SCHEMBL7845357 0.77 GABRA5 (0.71) ALDH1A1MEN1KMT2APOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005072731-A1 3-PHENYL-N- ((1, 3, 4) THIADIAZOL-2-YL) -ACRYLAMIDE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF ESTROGEN-RELATED RECEPTORS FOR THE TREATMENT OF E.G. CANCER, RHEUMATOID ARTHRITIS OR NEUROLOGICAL DISORDERS X-CEPTOR THERAPEUTICS, INC. (US) 2005-08-11 WO disclosed